# The Efficacy and Safety Study of 2107 Injection in Subjects With Mild to Moderate Knee Osteoarthritis

> **NCT07746843** · NA · NOT_YET_RECRUITING · sponsor: **BioRegen Biomedical (Changzhou) Co., Ltd** · enrollment: 286 (estimated)

## Conditions studied

- Mild Knee Osteoarthritis
- Moderate Knee Osteoarthritis

## Interventions

- **DEVICE:** 2107 Injection
- **DEVICE:** DUROLANE®

## Key facts

- **NCT ID:** NCT07746843
- **Lead sponsor:** BioRegen Biomedical (Changzhou) Co., Ltd
- **Sponsor class:** INDUSTRY
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** NOT_YET_RECRUITING
- **Start date:** 2026-09-01
- **Primary completion:** 2028-06-30
- **Final completion:** 2028-12-31
- **Target enrollment:** 286 (ESTIMATED)
- **Last updated:** 2026-08-06


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07746843

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07746843, "The Efficacy and Safety Study of 2107 Injection in Subjects With Mild to Moderate Knee Osteoarthritis". Retrieved via MORVS 2026-10-21 from https://api.morvs.ai/clinical/NCT07746843. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*